BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 38089759)

  • 1. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer.
    Shi W; Xu C; Lei P; Sun X; Song M; Guo Y; Song W; Li Y; Yu L; Zhang H; Wang H; Zhang DL
    Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38834774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
    He L; Lin Y; Huang P; Pan H
    Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis.
    Pei L; Li Y; Gu H; Wang S; Wu W; Fan S; Shi X; Si X
    Clin Transl Oncol; 2024 May; ():. PubMed ID: 38773061
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jin T; Park KS; Nam SE; Lim SH; Kim JH; Noh WC; Yoo YB; Park WS; Yun IJ
    Ann Surg Treat Res; 2024 May; 106(5):263-273. PubMed ID: 38725802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer.
    Gao P; Sun N; Zhao T; Sun Y; Gu J; Ma D; Tian H; Peng Z; Zhang Y; Han F; Qi X
    Cancer Innov; 2022 Oct; 1(3):252-269. PubMed ID: 38089759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
    Cheng T; Chen P; Chen J; Deng Y; Huang C
    Front Genet; 2021; 12():809600. PubMed ID: 35069702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining the prognostic significance and immune infiltration of
    Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
    Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
    Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
    Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.
    Ozturk H; Cingoz H; Tufan T; Yang J; Adair SJ; Tummala KS; Kuscu C; Kinali M; Comertpay G; Nagdas S; Goudreau BJ; Luleyap HU; Bingul Y; Ware TB; Hwang WL; Hsu KL; Kashatus DF; Ting DT; Chandel NS; Bardeesy N; Bauer TW; Adli M
    Dev Cell; 2022 Jun; 57(11):1331-1346.e9. PubMed ID: 35508175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLK1 Inhibition Sensitizes Breast Cancer Cells to Radiation via Suppressing Autophagy.
    Wang B; Huang X; Liang H; Yang H; Guo Z; Ai M; Zhang J; Khan M; Tian Y; Sun Q; Mao Z; Zheng R; Yuan Y
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1234-1247. PubMed ID: 33621661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.